Xuejiao Wang

100 Haining Road
Shanghai, 200080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Gut microbiome predicts personalized responses to dietary fiber in prediabetes: a randomized, open-label trial.

Gut microbiome predicts personalized responses to dietary fiber in prediabetes: a randomized, open-label trial.

Journal: Nature communications

Published: July 03, 2025

Glucagon-like peptide-1 receptor agonists ameliorate polycystic ovarian syndrome in mice by regulating the irisin level and activating the BMP4-Smad signaling pathway†.

Glucagon-like peptide-1 receptor agonists ameliorate polycystic ovarian syndrome in mice by regulating the irisin level and activating the BMP4-Smad signaling pathway†.

Journal: Biology of reproduction

Published: December 10, 2024

A core microbiome signature as an indicator of health.

A core microbiome signature as an indicator of health.

Journal: Cell

Published: December 09, 2023

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention.

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: November 30, 2023

Microbiome Features Differentiating Unsupervised-Stratification-Based Clusters of Patients with Abnormal Glycometabolism.

Microbiome Features Differentiating Unsupervised-Stratification-Based Clusters of Patients with Abnormal Glycometabolism.

Journal: mBio

Published: January 18, 2023

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†.

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†.

Journal: Biology of reproduction

Published: November 15, 2022

Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota.

Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota.

Journal: Frontiers in endocrinology

Published: August 28, 2022

Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARα.

Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARα.

Journal: Lipids in health and disease

Published: January 18, 2022

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.

Journal: Frontiers in endocrinology

Published: October 31, 2021

Factors associated with progression of different prediabetic status to Diabetes: A Community-based cohort study.

Factors associated with progression of different prediabetic status to Diabetes: A Community-based cohort study.

Journal: Diabetes research and clinical practice

Published: October 16, 2021

Prevalence and risk factors of diabetes mellitus: a community-based sectional survey.

Prevalence and risk factors of diabetes mellitus: a community-based sectional survey.

Journal: Annals of palliative medicine

Published: September 22, 2021

Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.

Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.

Journal: Frontiers in endocrinology

Published: September 21, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026